Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Epinoma
AddedMar 20, 2024
UpdatedJul 3, 2026
Epinoma

Epinoma

Pre-Seed

Innovative diagnostics company using multi-omics for cancer monitoring. Founded in 2020, based in San Francisco.

HQ
San Francisco, CA, US
Founded
2020
Accelerator
Y Combinator logoY CombinatorS21
Overview
Compare
Fundraising
Employees
Website

Epinoma, founded in 2020 and headquartered in San Francisco, California, is a diagnostics company specializing in the multi-omics approach to cancer monitoring. The company's core mission is to revolutionize cancer diagnostics by engineering proteins that control the operating system of biology. Epinoma aims to provide more accurate and comprehensive cancer monitoring solutions, leveraging advanced multi-omics techniques to offer cutting-edge diagnostic services.

Notable affiliated individuals and investors include leading experts in biotechnology and prominent venture capital firms. Epinoma has achieved significant milestones in developing its proprietary multi-omics platform, which has shown promising results in early trials. The overall impact of Epinoma's work is poised to enhance the precision and effectiveness of cancer diagnostics, potentially leading to earlier detection and better patient outcomes.

Epinoma - Similar Companies

Freenome logo

Freenome

freenome.com

Epi One logo

Epi One

epi-one.com

Micronoma logo

Micronoma

micronoma.com

Epic Sciences logo

Epic Sciences

epicsciences.com

PrognomiQ logo

PrognomiQ

prognomiq.com

Isabl logo

Isabl

isabl.io

Complete Omics logo

Complete Omics

completeomics.com

NantOmics logo

NantOmics

nantomics.com

Episteme Prognostics logo

Episteme Prognostics

epistemedx.com

GRAIL logo

GRAIL

grail.com

Numen logo

Numen

numen.com

Oncodea logo

Oncodea

oncodea.com

Episona logo

Episona

OnCirc Diagnostics logo

OnCirc Diagnostics

Triomics logo

Triomics

triomics.com

Epinoma - Quick Facts

Who are Epinoma's competitors?

Companies similar to Epinoma include Freenome, Epi One, Micronoma and Epic Sciences.

When was Epinoma founded?

Epinoma was founded in 2020.

Where is Epinoma's headquarters located?

Epinoma's headquarters is located in San Francisco, CA, US.

When was Epinoma's last funding round?

Epinoma's most recent funding round was for $125k (USD) in September 2021.

How much has Epinoma raised to-date?

As of Sep 8, 2021, Epinoma has raised a total of $125k (USD).

How many employees does Epinoma have?

Epinoma has 6 employees as of Feb 24, 2024.

Epinoma - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Diagnostics
Tags
  • Data Information
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software